Who’s Driving? Switch of Drivers in Immunotherapy-Treated Progressing Sinonasal Melanoma

SIMPLE SUMMARY: Here, we monitored the course of the disease and treatment of sinonasal melanoma patients. Since treatment options are rare, immunotherapy is often the treatment of choice. However, intrinsic or acquired resistance to treatment may occur. We assessed the mutational status of the tumo...

Descripción completa

Detalles Bibliográficos
Autores principales: Freiberger, Sandra N., Turko, Patrick, Hüllner, Martin, Dummer, Reinhard, Morand, Grégoire B., Levesque, Mitchell P., Holzmann, David, Rupp, Niels J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198298/
https://www.ncbi.nlm.nih.gov/pubmed/34072863
http://dx.doi.org/10.3390/cancers13112725

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198298/
https://www.ncbi.nlm.nih.gov/pubmed/34072863
http://dx.doi.org/10.3390/cancers13112725

Ejemplares similares